Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 Years

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2013
This study evaluates the effect of different induction courses in children and adolescents with newly diagnosed acute myeloid leukemia. In the first course patients are randomised to receive either standard anthracycline therapy with mitoxantrone or experimental DaunoXome. In the second course patients are randomised between standard treatment with ADxE (cytarabine, DaunoXome, etoposide) or experimental therapy with FLADx (fludarabine, cytarabine, DaunoXome).
Epistemonikos ID: e6edfe29a680c4e920f0405150924eaa24a6a2fa
First added on: Jan 21, 2022